Baseline characteristics of patients with COVID-19
| Characteristic | All | Male | Female |
| Patients n | 205 | 112 | 93 |
| Age years | 51 (39–57) | 50 (36–57) | 51 (41–58) |
| Comorbidities | |||
| Diabetes | 10 (4.9%) | 7 (6.3%) | 3 (3.2%) |
| Hypertension | 23 (11.2%) | 13 (11.6%) | 10 (10.8%) |
| Cardiovascular disease | 2 (1.0%) | 1 (0.9%) | 1 (1.1%) |
| COPD | 9 (4.4%) | 5 (4.5%) | 4 (4.3%) |
| Cancer | 1 (0.5%) | 0 (0%) | 1 (1.1%) |
| Other | 8 (3.9%) | 7 (6.3%) | 1 (1.1%) |
| None | 163 (79.5%) | 87 (77.7%) | 76 (81.7%) |
| Signs and symptoms | |||
| Fever | 168 (82.0%) | 98 (87.5%) | 70 (75.3%) |
| Dry cough | 143 (69.8%) | 82 (73.2%) | 61 (65.6%) |
| Expectoration | 59 (28.8%) | 45 (40.2%) | 14 (15.1%) |
| Fatigue | 66 (32.2%) | 36 (32.1%) | 30 (32.3%) |
| Myalgia | 47 (22.9%) | 22 (19.6%) | 25 (26.9%) |
| Chest tightness/shortness of breath | 71 (34.6%) | 33 (29.5%) | 38 (40.9%) |
| Chest pain | 10 (4.9%) | 4 (3.6%) | 6 (6.5%) |
| Haemoptysis | 8 (3.9%) | 7 (6.3%) | 1 (1.1%) |
| Stuffy nose/runny nose/pharyngalgia/headache | 54 (26.3%) | 36 (32.1%) | 18 (19.4%) |
| Diarrhoea | 29 (14.1%) | 15 (13.4%) | 14 (15.1%) |
| Nausea | 11 (5.4%) | 4 (3.6%) | 7 (7.5%) |
| Vomiting | 6 (2.9%) | 2 (1.8%) | 4 (4.3%) |
| Laboratory findings | |||
| White blood cell count ×109 per L | 5.3 (4.3–6.5) | 5.5 (4.7–6.7) | 5.1 (3.8–6.4) |
| Neutrophil count % | 65.3 (56.3–70.9) | 67.3 (58.8–72.4) | 62.0 (53.3–70.2) |
| Lymphocyte count % | 23.4 (18.3–31.1) | 22.2 (17.1–28.8) | 24.7 (19.5–33.7) |
| Platelet count ×109 per L | 166 (137–219) | 164 (134–218) | 167 (144–219) |
| Bilateral distribution of patchy shadows or ground-glass opacity on CT | 200 (97.6%) | 111 (99.1%) | 89 (95.7%) |
| Temperature on admission C | 36.5 (36.3–36.8) | 36.5 (36.2–36.7) | 36.7 (36.5–36.9) |
| Heart rate on admission beats per min | 86 (77–96) | 88 (79–100) | 84 (75–90) |
| Respiratory rate on admission breaths per min | 20 (16–20) | 20 (18–22) | 18 (16–18) |
| Arterial pressure on admission mmHg mean±sd | 96.8±11.3 | 98.3±11.8 | 95.0±10.4 |
| SpO2 % | 96 (96–97) | 96 (95–97) | 97 (96–98) |
| Treatments | |||
| Antibiotics | 128 (62.4%) | 73 (65.2%) | 55 (59.1%) |
| Antiviral | 163 (79.5%) | 91 (81.3%) | 72 (77.4%) |
| Chinese medicine | 173 (84.4%) | 97 (86.6%) | 76 (81.7%) |
Data are presented as median (range) or n (%), unless otherwise stated. CT: computed tomography; SpO2: oxygen saturation measured by pulse oximetry.